search
Back to results

Effect of Simethicone on Eustachian Tube Dysfunction

Primary Purpose

Otitis Media

Status
Completed
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
Simethicone
Placebo
Sponsored by
University of Pittsburgh
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Otitis Media focused on measuring Eustachian tube, otitis, middle-ear pressure, simethicone

Eligibility Criteria

18 Years - 50 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age 18 to 50 years
  • Healthy subjects other than current upper respiratory tract infection ("cold")
  • Jackson Score of 6 on screening
  • Subject reports symptom onset within 4 days of entry visit
  • Unilateral or bilateral middle-ear pressure <-50 mmH2O

Exclusion Criteria:

  • Otoscopic diagnosis of unilateral or bilateral otitis media
  • Presence of tympanostomy tubes or tympanic membrane perforations bilaterally
  • Asthma or any chronic medical disease or condition
  • Use of an "over the counter" medicine within 24 hours of study or prescription within 4 weeks of the study day (except birth control)
  • Use of an experimental drug within 3 months of study
  • An unusual or allergic reaction to simethicone, food dyes, or preservatives
  • Pregnancy or breast feeding
  • Ear surgery other than tympanostomy tube insertion

Sites / Locations

  • Middle Ear Physiology Laboratory of Children's Hospital of PIttsburgh of UPMC

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

simethicone

placebo

Arm Description

125 mg tablet

chewable calcium tablet

Outcomes

Primary Outcome Measures

Fraction of Middle Ear (ME) Pressure Equilibrated (FGE)
The proportion of the pressure chamber-ME pressure gradient equilibrated with 1 swallow

Secondary Outcome Measures

Full Information

First Posted
March 9, 2011
Last Updated
June 23, 2016
Sponsor
University of Pittsburgh
search

1. Study Identification

Unique Protocol Identification Number
NCT01312038
Brief Title
Effect of Simethicone on Eustachian Tube Dysfunction
Official Title
A Pilot Study of the Effect of Simethicone in Adult Subjects With a Common Cold on Eustachian Tube Dysfunction
Study Type
Interventional

2. Study Status

Record Verification Date
June 2016
Overall Recruitment Status
Completed
Study Start Date
March 2011 (undefined)
Primary Completion Date
July 2014 (Actual)
Study Completion Date
July 2014 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Pittsburgh

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
This study is designed to measure the effects of a chewable Simethicone tablet taken by mouth on middle-ear pressure in adults with a common cold and evidence of abnormal middle-ear pressure. In children and adults, middle-ear diseases such as otitis media (the buildup of fluid within the middle ear) and a form of temporary hearing loss occur if the Eustachian tube does not open, does not open often enough or is always open. Simethicone, available over-the-counter under several brand names including Gas-X, may help break up the bubbles that may block the opening of the Eustachian tube in the back of the nose during a cold, allowing air to pass between the nose and middle ear. This study requires a single visit to the Middle Ear Physiology Laboratory in the Oakland section of Pittsburgh. If eligible for the study, Eustachian tube function testing will be done; the Simethicone tablet or placebo (a tablet that looks and tastes like the Simethicone tablet but has no active ingredient) will be given and Eustachian tube function testing repeated.
Detailed Description
For the Eustachian tube function testing, the subject and a technician are seated comfortably within a pressure chamber, a room-like chamber in which the air pressure can be varied much like in an airplane or submarine. Middle ear pressure will be measured in each ear by tympanometry, a test done by inserting a small probe (an earplug attached to a rubber or plastic tube that measures ear pressure) half-way into the ear canal and changing the pressure in the probe. Then, microphones will be placed in the ear canals and a sound source placed into one nostril. The chamber pressure is then decreased and increased to various pressures and middle ear pressure is measured at these various pressures.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Otitis Media
Keywords
Eustachian tube, otitis, middle-ear pressure, simethicone

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
25 (Actual)

8. Arms, Groups, and Interventions

Arm Title
simethicone
Arm Type
Experimental
Arm Description
125 mg tablet
Arm Title
placebo
Arm Type
Placebo Comparator
Arm Description
chewable calcium tablet
Intervention Type
Drug
Intervention Name(s)
Simethicone
Intervention Description
single 125 mg chewable tablet
Intervention Type
Drug
Intervention Name(s)
Placebo
Intervention Description
chewable calcium tablet
Primary Outcome Measure Information:
Title
Fraction of Middle Ear (ME) Pressure Equilibrated (FGE)
Description
The proportion of the pressure chamber-ME pressure gradient equilibrated with 1 swallow
Time Frame
After achieving the desired ME-pressure chamber gradient at baseline and 30 min post treatment

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age 18 to 50 years Healthy subjects other than current upper respiratory tract infection ("cold") Jackson Score of 6 on screening Subject reports symptom onset within 4 days of entry visit Unilateral or bilateral middle-ear pressure <-50 mmH2O Exclusion Criteria: Otoscopic diagnosis of unilateral or bilateral otitis media Presence of tympanostomy tubes or tympanic membrane perforations bilaterally Asthma or any chronic medical disease or condition Use of an "over the counter" medicine within 24 hours of study or prescription within 4 weeks of the study day (except birth control) Use of an experimental drug within 3 months of study An unusual or allergic reaction to simethicone, food dyes, or preservatives Pregnancy or breast feeding Ear surgery other than tympanostomy tube insertion
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
William J Doyle, PhD
Organizational Affiliation
Department of Otolaryngology, Children's Hospital of Pittsburgh of UPMC
Official's Role
Principal Investigator
Facility Information:
Facility Name
Middle Ear Physiology Laboratory of Children's Hospital of PIttsburgh of UPMC
City
Pittsburgh
State/Province
Pennsylvania
ZIP/Postal Code
15213
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Effect of Simethicone on Eustachian Tube Dysfunction

We'll reach out to this number within 24 hrs